You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 20, 2024

Investigational Drug Information for Gliolan


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Gliolan?

Gliolan is an investigational drug.

There have been 17 clinical trials for Gliolan. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.

The most common disease conditions in clinical trials are Glioblastoma, Brain Neoplasms, and Glioma. The leading clinical trial sponsors are photonamic GmbH & Co. KG, University Hospital, Lille, and medac GmbH.

Recent Clinical Trials for Gliolan
TitleSponsorPhase
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumorphotonamic GmbH & Co. KGPhase 1/Phase 2
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain TumorWestfälische Wilhelms-Universität MünsterPhase 1/Phase 2
Dose Finding for Intraoperative Photodynamic Therapy of GlioblastomaHemerion TherapeuticsPhase 2

See all Gliolan clinical trials

Clinical Trial Summary for Gliolan

Top disease conditions for Gliolan
Top clinical trial sponsors for Gliolan

See all Gliolan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.